Citation Impact
Citing Papers
Place of Cabergoline in Acromegaly: A Meta-Analysis
2011
Tumor Volume of Growth Hormone-Secreting Pituitary Adenomas during Treatment with Pegvisomant: A Prospective Multicenter Study
2009
Guidelines for Acromegaly Management: An Update
2009
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Effective Combination Treatment with Cabergoline and Low-Dose Pegvisomant in Active Acromegaly: A Prospective Clinical Trial
2012
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours
2001
Acromegaly
2006 Standout
Pegvisomant and cabergoline combination therapy in acromegaly
2012
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Ovarian stromal hypertrophy in hyperandrogenic women
1994
Diabetic Foot Ulcers and Their Recurrence
2017 Standout
COMPLICATIONS OF SURGERY FOR OBESITY
2001
Fluorescent Labeling of Purified β2 Adrenergic Receptor
1995 StandoutNobel
Descending control of pain
2002 Standout
Plasma Chromogranin A as Marker for Survival in Patients With Metastatic Endocrine Gastroenteropancreatic Tumors
2008
Clinical use of cabergoline as primary and adjunctive treatment for acromegaly
2008
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Lack of Utility of111In-Pentetreotide Scintigraphy in Localizing Ectopic ACTH Producing Tumors: Follow-Up of 18 Patients
1999
Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report
2007 Standout
Cushing's syndrome
2001
Receptor for Advanced Glycation End Products (RAGE) Signaling Induces CREB-dependent Chromogranin Expression during Neuronal Differentiation
2002
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Childhood obesity: public-health crisis, common sense cure
2002 Standout
Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study
2005 Standout
Cushing's syndrome
2015 Standout
Phaeochromocytoma
2005 Standout
A Reappraisal of the Utility of Somatostatin Receptor Scintigraphy in Patients with Ectopic Adrenocorticotropin Cushing’s Syndrome
2003
Growth Hormone Receptor Antagonists
2004
Effect of pegylation on pharmaceuticals
2003 Standout
Diagnosis and Treatment of Pituitary Tumors
1999
Cabergoline Decreases Somatotroph Adenoma Size: A Case Report
2004
Outcomes After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity
2000 Standout
Cyclic Cushing’s syndrome: a clinical challenge
2007
Gamma knife radiosurgery for acromegaly – long‐term experience
2006
Diagnosis and radioguided surgery with 111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid
1997
Inverse agonism: pharmacological curiosity or potential therapeutic strategy?
1995
Primary medical therapy for acromegaly
2003
Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes
2016 StandoutNobel
Raloxifene decreases serum IGF-I in male patients with active acromegaly
2004
Epidemiology of Acromegaly
1999
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Obesity
2005 Standout
Efficacy and Safety of Low-Carbohydrate Diets
2003
Cushing’s Syndrome Due to Ectopic Production of Corticotropin-Releasing Hormone in an Infant with Ganglioneuroblastoma
2003
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Octreotide
1996
The Rise and Fall of the Chemoattractant Receptor GPR33
2005 StandoutNobel
Cabergoline Therapy of Growth Hormone & Growth Hormone/Prolactin Secreting Pituitary Tumors
2004
Central and peripheral actions of somatostatin on the growth hormone–IGF-I axis
2004
CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome.
1999
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Clinical Pharmacokinetic, Pharmacodynamic, and Drug–Drug Interaction Profile of Canagliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor
2015
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Nelson’s Syndrome: Complete Remission with Cabergoline but Not with Bromocriptine or Cyproheptadine Treatment
2004
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
CLINICAL AND BIOCHEMICAL EVALUATION OF CUSHING'S SYNDROME
1997
Gene targeting — homing in on α2-adrenoceptor-subtype function
1997 StandoutNobel
Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome
2007
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status
2004
Is there a role for somatostatin and its analogs in Cushing's syndrome?
1996
The surgical treatment of morbid obesity
1998
Diabetes structured self-management education programmes: a narrative review and current innovations
2017
Syndrome X: A syndrome of insulin resistance. Epidemiological and clinical evidence
1994
Nutrition, hormones, and breast cancer: Is insulin the missing link?
1996
Dopamine Receptor Expression and Function in Corticotroph Pituitary Tumors
2004
Porous metal–organic-framework nanoscale carriers as a potential platform for drug delivery and imaging
2009 Standout
Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome
2001
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Endocrine and Metabolic Abnormalities in Adolescents with a PCOS-like Condition: Consequences for Adult Reproduction
1998
The Role of [18F]Fluorodeoxyglucose Positron Emission Tomography and [111In]-Diethylenetriaminepentaacetate-d -Phe-Pentetreotide Scintigraphy in the Localization of Ectopic Adrenocorticotropin-Secreting Tumors Causing Cushing’s Syndrome
2004
Endocrine investigation: Cushing's syndrome
1998
Cancer/testis antigens, gametogenesis and cancer
2005 Standout
Usefulness of Somatostatin Receptor Scintigraphy in Patients with Occult Ectopic Adrenocorticotropin Syndrome
1999
Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: From a complex constellation to a simple sequence of prenatal onset
1998
Cushing's syndrome
2006 Standout
Diabetes self-management education reduces risk of all-cause mortality in type 2 diabetes patients: a systematic review and meta-analysis
2016
Early Endocrine, Metabolic, and Sonographic Characteristics of Polycystic Ovary Syndrome (PCOS): Comparison between Nonobese and Obese Adolescents
2003
Surgery Decreases Long-term Mortality, Morbidity, and Health Care Use in Morbidly Obese Patients
2004 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Guidelines for Acromegaly Management
2002
Abnormalities in the serum insulin-like growth factor-1 axis in women with hyperandrogenism
1998
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation?
1992
Pituitary Lactotroph Adenomas Develop after Prolonged Lactotroph Hyperplasia in Dopamine D2 Receptor-Deficient Mice1
1999
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
2002
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
The structural basis of g-protein-coupled receptor function and dysfunction in human diseases
2007
Sex steroids and insulin resistance
2002
A twin study of polycystic ovary syndrome
1995
Optimizing Control of Acromegaly: Integrating a Growth Hormone Receptor Antagonist into the Treatment Algorithm
2003
Control of growth hormone and IGF 1 in patients with acromegaly in the UK : responses to medical treatment with somatostatin analogues and dopamine agonists
2013
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Polycystic ovary syndrome in adolescents: is there an epidemic?
2002
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Growth hormone treatment during suppression of early puberty in adopted girls
1999
Suppression of Rat and Human Growth Hormone and Prolactin Secretion by a Novel Somatostatin/Dopaminergic Chimeric Ligand
2003
Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
2002
Criteria for Cure of Acromegaly: A Consensus Statement
2000
Approach to the Patient with Persistent Acromegaly after Pituitary Surgery
2010
Cabergoline in the Treatment of Hyperprolactinemia: A Study in 455 Patients
1999
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
The Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
1998
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
2004
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Successful treatment of resistant acromegaly with a growth hormone receptor antagonist
2001
Premature Adrenarche—Normal Variant or Forerunner of Adult Disease?*
2000
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomant
2003
A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1
2000 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Mitohormesis: Promoting Health and Lifespan by Increased Levels of Reactive Oxygen Species (ROS)
2014
Long-Acting Peptidomimergic Control of Gigantism Caused by Pituitary Acidophilic Stem Cell Adenoma*
2000
[Fulminant type 1 diabetes].
2002
The Timing of Normal Puberty and the Age Limits of Sexual Precocity: Variations around the World, Secular Trends, and Changes after Migration
2003 Standout
Acromegaly: historical perspectives and current therapy
2001
Demonstration of Enhanced Potency of a Chimeric Somatostatin-Dopamine Molecule, BIM-23A387, in Suppressing Growth Hormone and Prolactin Secretion from Human Pituitary Somatotroph Adenoma Cells
2002
Mifepristone Effects on Tumor Somatostatin Receptor Expression in Two Patients with Cushing's Syndrome due to Ectopic Adrenocorticotropin Secretion
2011
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
A Critical Analysis of Pituitary Tumor Shrinkage during Primary Medical Therapy in Acromegaly
2005
Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions*
1997
Fulminant Type 1 Diabetes
2003
The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
2008 Standout
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update
2011
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Works of Frank Nobels being referenced
Delivering Diabetes Education through Nurse-Led Telecoaching. Cost-Effectiveness Analysis
2016
Neuroendocrine Tumor Markers
2001
Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis
1992
Chromogranin A as Serum Marker for Neuroendocrine Neoplasia: Comparison with Neuron-Specific Enolase and the α-Subunit of Glycoprotein Hormones
1997
Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries
2012
Hyperfunctioning unilateral adrenal macronodule in three patients with Cushing's disease: hormonal and imaging characterization
1993
Relation between Disease Phenotype and HLA-DQ Genotype in Diabetic Patients Diagnosed in Early Adulthood
2002
Somatostatin receptor scintigraphy: Its value in tumor localization in patients with cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion
1994
In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand
1996
The German and Belgian accreditation models for diabetic foot services
2015
Cabergoline in the Treatment of Acromegaly: A Study in 64 Patients
1998
Hypertension in obese and non-obese non-insulin dependent diabetics a matter of regional adiposity?
1988
Weight reduction with a high protein, low carbohydrate, calorie-restricted diet: effects on blood pressure, glucose and insulin levels.
1989
Optimizing diabetes control in people with Type 2 diabetes through nurse‐led telecoaching
2016
A case of malnutrition after biliopancreatic diversion for morbid obesity.
1993
Allogeneic bone marrow transplantation for plasma cell leukemia following melphalan, cyclophosphamide and total body irradiation.
1989